Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oracea and Epiduo Forte in Severe Acne
NCT03457636Phase 4Completed
- Sponsor
- DermResearch
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doxycycline and Epiduo Forte in acne vulgaris, sponsored by DermResearch. Primary endpoint: Investigator Global Assessment at 12 weeks. Started Mar 2018; status: completed.
02
Drugs
doxycyclineEpiduo Forte
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03457636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03457636.